A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: a population-based study

Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer

(2018) Yanfeng Gao et al.   Scientific Reports

Exploration of the Optimal Minimum Lymph Node Count after Colon Cancer Resection for Patients Aged 80 Years and Older

(2016) Xu Guan et al.   Scientific Reports

The Characteristics of Bone Metastasis in Patients with Colorectal Cancer: A Long-Term Report from a Single Institution

(2015) Se-Jin Baek et al.   WORLD JOURNAL OF SURGERY

Risk factors for the development of metachronous bone metastasis in colorectal cancer patients after curative resection

(2015) Chang Sun et al.   International Journal of Surgery

Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival

(2015) Pragatheeshwar Thirunavukarasu et al.   JAMA Surgery

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Investigating the association between polymorphisms in connective tissue growth factor and susceptibility to colon carcinoma

(2014) ABRAR AHMAD et al.   Molecular Medicine Reports

Survival Differences in Patients With Metastatic Colorectal Cancer and With Single Site Metastatic Disease at Initial Presentation: Results From South Australian Clinical Registry for Advanced Colorectal Cancer

(2012) Muhammad A. Khattak et al.   Clinical Colorectal Cancer

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

(2011) Satoshi Watanabe et al.   BMC CANCER